Certara’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Certara provides model-informed drug development, regulatory science and label optimization solutions for biopharmaceutical companies. Read more

William F. Feehery's photo - CEO of Certara

CEO

William F. Feehery

CEO Approval Rating

90/100

Founded:

2008

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Schrodinger is a top competitor of Certara. Schrodinger is a Public company that was founded in 1990 in New York, New York. Schrodinger operates in the Biotechnology industry. Compared to Certara, Schrodinger has 458 fewer employees.

Numerate is seen as one of Certara's biggest rivals. Numerate was founded in 2007, and is headquartered in San Francisco, California. Numerate operates in the Biotechnology industry. Numerate generates $191.7M less revenue vs. Certara.

Simulations Plus is seen as one of Certara's top competitors. Simulations Plus was founded in Lancaster, California} in 1996. Simulations Plus competes in the Health Care Services industry. Compared to Certara, Simulations Plus generates $159.9M less revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 850 a good estimate for Certara's Employee count?

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Feb 2020

Source »
undisclosed
-
Pirana Software & Consulting BV

Sep 2018

Source »
undisclosed
Pirana is a pharmacometrics modeling software that allows developers to create, manage and evaluate chemical models and outputs for drug development.
Analytica Laser

Apr 2018

Source »
undisclosed
Analytica Laser provides medicines and health technologies consulting, research and data services for biopharmaceutical and medical device manufacturers.
BaseCase Management GmbH

Feb 2018

Source »
undisclosed
BaseCase is a Software-as-a-Service company that develops and deploys web-based applications for the pharmaceutical and medical device companies.
d3 Medicine, LLC.

Sep 2016

Source »
undisclosed
d3 Medicine is a biopharmaceutical strategic advisory firm that provides strategic planning and stewardship of complex drug development programs.

These are all the companies that Certara has acquired. Certara has acquired 8 companies and its latest acquisition was in Feb 2020.

Investments

No recent investments found related to Certara

Certara News

May 8, 2020Applied Clinical Trials

Certara & DMTC Chloroquine COVID-19 Collaboration

Certara and DMTC Ltd have entered into a research collaboration to evaluate the preventative use of c... See more »
April 7, 2020Medical Buyer

Certara Launches COVID-19 Pharmacology Online Resource Center

Certara®, the global leader in model-informed drug development, announced today that it has launched ... See more »
February 27, 2020Pharmabiz

Certara acquires modelling & simulation platform for neurodegenerative diseases from In Silico Biosciences

Certara, the global model─informed drug development and decision support leader, has acquired a range... See more »
February 10, 2020BioPortfolio

Arvinas Selects Certara to Advance Speed and Efficiency of Its Targeted Protein Degradation Research

Certaras D360 platform enables Arvinas to accelerate lead identification and optimization processes f... See more »
January 27, 2020Pharmabiz

Certara announces over 90% of US FDA new drug approvals in 2019 supported by its software/consulting services

Certara, the global model─informed drug development and decision support leader, reported that more t... See more »
January 10, 2020Pharmabiz

Certara partners with Galderma in advancing modelling & simulation technology to attain US FDA nod of Aklief acne cream

Certara, the global model─informed drug development and decision support leader, announced that its S... See more »
December 12, 2019Pharmabiz

LEO Pharma joins Certara's PBPK Simcyp Simulator Consortium

Certara, the global model─informed drug development and decision support leader, announced that LEO P... See more »

Certara Blogs

May 22, 2020Certara Blog

The Defining Role of Clinical Pharmacology for COVID-19 Drug Development

Clinical pharmacology provides a valuable opportunity to accelerate the near-term development of exis... See more »
May 18, 2020Certara Blog

The Value of Modeling and Simulation in Vaccine Development

A quantitative modeling approach can be used to predict the optimal time to administer influenza vacc... See more »
May 7, 2020Certara Blog

Formulary Decision Making: Must Have Instruments in Value Translation

Innovative contracts are helpful in navigating an evolving pharma marketplace while providing new app... See more »
April 30, 2020Certara Blog

Applying Decision Analysis to Drug Development for COVID-19 & Future Pandemics

This blog discusses how decision analysis approaches can help drug developers to better decisions und... See more »
April 9, 2020Certara Blog

Predicting Drug Exposure in Cancer Patients Using a PBPK Oncology Population

PBPK modeling using a virtual oncology population can help to predict exposure and accelerate the dev... See more »
March 27, 2020Certara Blog

A QSP Modeling Approach for Neurodegenerative Disease Drug Development

A QSP model was built to evaluate its use in drug discovery for complex neurodegenerative diseases, e... See more »
February 27, 2020Certara Blog

Using Modeling and Simulation to Optimize the Timing of Maternal Influenza Vaccination

A M&S model was built to offer an alternate approach to dedicated timing studies to determine th... See more »

Certara Press Releases

December 7, 2019PRcom

Scilligence and Certara Partner to Improve Client's Data Analysis and Visualization

Scilligence has partnered with Certara to enable advanced data analysis and visualization capabilitie... See more »
July 27, 2017PR Newswire

Large Number of Applications in Academics, Industrial & Commercial Sectors

DUBLIN, July 28, 2017 /PRNewswire/ -- The "Global Computational Biology Market Insights, Opportunity,... See more »
July 11, 2017PR Newswire

Arsenal announces sale of Certara, retains significant minority investment stake

NEW YORK, July 11, 2017 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal") today announced that it ... See more »
June 8, 2017Business Wire

Global Computational Biology Market to Reach $11.4 Billion by 2025 - Wide Usage of Computational Biology in Biotechnology & Pharmaceuticals - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Computational... See more »
August 16, 2016Business Wire

Global Bio Simulation Market Trends Analysis & Forecasts to 2021 - Market is Projected to Reach USD 2.28 Billion - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Bio Simulatio... See more »
June 16, 2016BizPR

Global Metabolomics Market Growth Trends, Key Players, Competitive Strategies and Forecasts 2015 - 2021 - Acute Market Reports

Biosimulation is explained as a computer-aided mathematical simulation of biological processes and sy... See more »
April 28, 2016Business Wire

Certara Launches New E-learning Platform for Biosimulation Education

PRINCETON, N.J.--(BUSINESS WIRE)--Certara today launched an e-learning platform to satisfy the increa... See more »

Certara Videos

Social Statistics

Headquarters

100 Overlook Center Suite 101

Princeton, New Jersey08540

609-716-7900

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Certara provides model-informed drug development, regulatory science and label optimization solutions for biopharmaceutical companies. Certara was founded in 2008. Certara's headquarters is located in Princeton, New Jersey, USA 08540. Certara's CEO, ...

CEO

Certara's CEO, William F. Feehery, currently has an approval rating of 90%. Certara's primary competitors are Schrodinger, Numerate & Simulations Plus.

Website

certara.com

Frequently Asked Questions about Certara

  1. When was Certara founded?

    Certara was founded in 2008
  2. Who is Certara's CEO?

    Certara's CEO is William F. Feehery
  3. How much revenue does Certara generate?

    Certara generates $200M in revenue
  4. How much funding does Certara have?

    Certara has historically raised $0 in funding
  1. Where is Certara's headquarters?

    Certara's headquarters is in Princeton New Jersey, USA
  2. How many employees does Certara have?

    Certara has 850 employees
  3. What sector does Certara operate in?

    Certara is in Health Care Services
  4. Who are Certara's competitors?

    Certara's top competitors are Schrodinger, Numerate, Simulations Plus